• Join
  • Login
  • Contact

Search abstracts

Nanoparticle Characterization for Cancer Therapeutics and Diagnostics: Lessons Learned from NCI’s Nanotechnology Characterization Lab (NCL)

  • At: 2012 FIP Congress in Amsterdam (the Netherlands)
  • Type: Presentation
  • By: MCNEIL, Scott (Frederick National Lab for Cancer Research, SAIC-Frederick/Nanotechnology Characterization Lab, Frederick, United States of America)
  • Abstract:

    AbstractNCI's Nanotechnology Characterization Laboratory (NCL) conducts preclinical efficacy and toxicity testing of nanoparticles intended for cancer therapeutics and diagnostics. The NCL is a collaborating partnership between NCI, the U.S. Food and Drug Administration (FDA) and the National Institute of Standards and Technology (NIST). The NCL


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses